| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.4M | — |
| R&D Expense | $42.8M | +84.0% |
| SG&A Expense | $14.0M | +30.1% |
| Operating Income | -$46.4M | -36.4% |
| Pre-tax Income | -$45.3M | -34.2% |
| Income Tax | $0 | — |
| Net Income | -$45.3M | -34.3% |
| EPS (Basic) | -$1.60 | +9.6% |
| EPS (Diluted) | -$1.60 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.0M | +327.3% |
| Current Assets | $80.9M | -28.8% |
| Total Assets | $95.8M | -17.1% |
| Current Liabilities | $13.9M | +130.5% |
| Stockholders' Equity | $71.5M | -34.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.9M | -26.6% |
| Capital Expenditures | $1.6M | +754.7% |
| Investing Cash Flow | $47.2M | +151.6% |
| Financing Cash Flow | $5.5M | -95.0% |
| Free Cash Flow | -$43.5M | -30.8% |
| +9.6% |